| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |